Your browser doesn't support javascript.
loading
Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447].
Ochsenreither, S; Fiedler, W M; Del Conte, G; Macchini, M; Matos, I; Habel, B; Ahrens-Fath, I; Raspagliesi, F; Lorusso, D; Keilholz, U; Rolling, C; Kebenko, M; Klinghammer, K F; Saavedra, O; Baumeister, H; Zurlo, A; Garralda, A.
Afiliação
  • Ochsenreither S; Charité Comprehensive Cancer Center, Berlin; Charité, Department of Hematology, Oncology and Tumor Immunology, Berlin; German Cancer Consortium (DKTK), Berlin. Electronic address: sebastian.ochsenreither@charite.de.
  • Fiedler WM; University Medical Center Hamburg-Eppendorf, Hubertus-Wald University Cancer Center, Hamburg, Germany.
  • Del Conte G; Fondazione IRCCS San Raffaele Hospital, Milan, Italy.
  • Macchini M; Fondazione IRCCS San Raffaele Hospital, Milan, Italy.
  • Matos I; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
  • Habel B; Glycotope GmbH, Berlin, Germany.
  • Ahrens-Fath I; Glycotope GmbH, Berlin, Germany.
  • Raspagliesi F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Lorusso D; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Keilholz U; Charité Comprehensive Cancer Center, Berlin; German Cancer Consortium (DKTK), Berlin; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Rolling C; University Medical Center Hamburg-Eppendorf, Hubertus-Wald University Cancer Center, Hamburg, Germany.
  • Kebenko M; University Medical Center Hamburg-Eppendorf, Hubertus-Wald University Cancer Center, Hamburg, Germany.
  • Klinghammer KF; Charité Comprehensive Cancer Center, Berlin; Charité, Department of Hematology, Oncology and Tumor Immunology, Berlin.
  • Saavedra O; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
  • Baumeister H; Glycotope GmbH, Berlin, Germany.
  • Zurlo A; Glycotope GmbH, Berlin, Germany.
  • Garralda A; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
ESMO Open ; 7(4): 100549, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35841804
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article